PCSA PROCESSA PHARMACEUTICALS INC

Ownership history in HRT FINANCIAL LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which HRT FINANCIAL LP reported a position in PROCESSA PHARMACEUTICALS INC (PCSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 19,691 -12,280 -38.4% 0.00% $56K $2.88
2024 Q4 INITIATED 31,971 0.00% $28K $22.10
% of Fund (quarterly)    PCSA price (monthly, adj. close)
← Back to HRT FINANCIAL LP Holdings